About

Elizabeth Jungman

Elizabeth Jungman

  • Director
  • Drug Safety & Innovation,
  • The Pew Charitable Trusts,

Profile

Elizabeth Jungman directs Pew’s work on drug safety and innovation, overseeing Pew’s initiatives related to antibiotics and innovation, drug safety, and prescription drug abuse. Before joining Pew, she served as a senior health policy adviser with the Senate Committee on Health, Education, Labor, and Pensions, where she played a key role in drafting and negotiating the Food and Drug Administration Safety and Innovation Act of 2012, the FDA provisions in the Pandemic All-Hazards Preparedness Reauthorization Act of 2013, and the Drug Quality and Security Act of 2013, which included drug compounding and supply chain security measures. Before moving to the Hill, Jungman was in private legal practice, where she counseled clients on a broad range of FDA regulatory matters and other health care issues related to the human pharmaceutical industry. She has an undergraduate biology degree from Harvard College, a J.D. from Georgetown University, and a master’s degree in public health from Johns Hopkins University. 

Recent Work

View All

Media Contact

Linda Paris

Officer, Communications

202.540.6354